Back to GALE Stock Lookup

GALE – FDA

Apr 3, 2014 07:06 AM GALENA BIOPHARMA (GALE) Presenting at 13th Annual Needham Healthcare Conference
Mar 18, 2014 09:24 AM Noble Financial Remains Netural on Galena's (GALE) Legal Issues; Maintains 'Buy' Rating
Mar 3, 2014 08:10 AM Galena Biopharma (GALE) Launches Galena Patient Services Support Program
Feb 28, 2014 07:20 AM Galena (GALE) Receives Patent for NeuVax in Australia
Feb 12, 2014 10:11 AM UPDATE: Galena Biopharma (GALE) Declines Following Negative Comments from Adam Feuerstein
Feb 3, 2014 08:27 AM Noble Financial Lifts PT on Galena (GALE) to $6 Amid Outlook for GALE-401
Jan 17, 2014 07:06 AM Galena Biopharma (GALE) Plans Presentation at Noble Financial Capital Markets 'X' Equity Conference
Jan 14, 2014 08:37 AM Roth Capital Raises PT on Galena Biopharma (GALE) Following Deal with Dr. Reddy's (RDY)
Jan 14, 2014 07:13 AM Galena Biopharma (GALE) Enters NeuVax Licensing Agreement with Dr. Reddy's (RDY)
Jan 13, 2014 09:31 AM Roth Capital Raises PT on Galena Biopharma (GALE) Following Mills Pharmaceuticals Purchase
Jan 13, 2014 07:37 AM Galena Biopharma (GALE) Acquires GALE-401 Rights Owner, Mills Pharmaceuticals
Jan 7, 2014 07:05 AM Galena Biopharma (GALE) Enrolls First Patient in GALE-301 Phase 2
Nov 11, 2013 07:07 AM Galena Biopharma (GALE) Presents Data from FBP Vaccine Phase 1 at SITC
Oct 7, 2013 07:16 AM Galena Biopharma (GALE) to Present Data from NeuVax Phase 2
Oct 3, 2013 07:07 AM Galena Biopharma (GALE) Announces Launch of Abstral Tabs in U.S.
Sep 3, 2013 07:07 AM Galena Biopharma (GALE) Initiates RELIEF to Evaluate Abstral as BTcP
Jun 3, 2013 07:07 AM Galena Biopharma (GALE) Issues Update to FBP-E39 Phase 1/2 at ASCO
Dec 7, 2012 07:12 AM Galena (GALE) Presents New Data on SN-33, NeuVax Phase 1/2
Dec 6, 2012 07:08 AM Galena Biopharma (GALE), Leica Biosystems Enter NeuVax Partnership
Dec 4, 2012 07:08 AM Galena Biopharma (GALE) Enters NeuVax Commercialization Agreement w/ Teva (TEVA)
Oct 26, 2012 07:09 AM Galena Biopharma (GALE) Presents Data from NeuVax Phase 1/2 in Breast Cancer
Aug 13, 2012 07:10 AM Galena Biopharma (GALE) Gets Japanese Patent for FBP Peptide Variants
Jun 5, 2012 07:08 AM Galena Biopharma (GALE) NeuVax Continues w/ Strong Safety Profile
Jun 4, 2012 07:07 AM Galena Biopharma (GALE) Updates from NeuVax Phase 1/2 Following Booster Inoculations; Will Present at ASCO
May 1, 2012 07:06 AM Galena Biopharma (GALE) Gets U.S. Patent Allowance for FBP Peptide Variants
Feb 14, 2012 07:06 AM Galena Biopharma (GALE) Initiates E39 Phase 1/2 in Two Gynecological Cancers
Jan 20, 2012 07:06 AM Galena Biopharma (GALE) Initiates NeuVax Phase 3
Jan 5, 2012 07:14 AM Galena Biopharma Announces IND for Phase 2 Trial for NeuVax Combined With Herceptin
Dec 9, 2011 07:06 AM Galena Biopharma (GALE) Updates on NeuVax w/ Herceptin Phase 2 Design
Dec 7, 2011 07:06 AM Galena (GALE) Reports Statistically Significant Data for NeuVax from Phase 2

Back to GALE Stock Lookup